Onyx Biotec’s ₹29.34 crore IPO saw massive demand, with a total subscription of 198.08 times on its final day, November 18.
Non-Institutional Investors (NIIs) led the charge, bidding 603.21 times for the 6.88 lakh shares reserved for them. Retail investors applied for 18.92 crore shares, leading to a 118.25x subscription. Qualified Institutional Buyers (QIBs) bid 32.49 times for their quota. Priced between ₹58-61 per share, the IPO raised funds to upgrade facilities, repay debts, and support business needs. Shares will list on NSE SME Emerge on November 21.